ANI Pharmaceuticals announced the launch of Pentoxifylline Extended-Release Tablets, USP 400mg. ANI’s Pentoxifylline ER Tablets are the generic version of the Reference Listed Drug Trental. The current annual U.S. market for Pentoxifylline ER Tablets is approximately $19.7M, according to latest estimates from IQVIA/IMS Health, a leading healthcare data and analytics provider.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ANIP:
